An observational study in Pregnancy Complication, Aortic Dissection and Marfan Syndrome, sponsored by DeltaHealth Hospital · Shanghai. Recruiting at 4 sites in China. Open to female participants aged 16 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-07-17.
Sponsored by DeltaHealth Hospital · Shanghai · Observational
A multicenter observational study on pregnancy-related aortic dissection
411 studies on the registry are indexed under Pregnancy Complications; 113 are open to participants now.
This study's planned enrollment of 500 is above the median of 400 across 198 observational studies indexed under Pregnancy Complications.
Browse Pregnancy Complications studies →This is the only study on the registry with DeltaHealth Hospital · Shanghai as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Women who sustained aortic dissection that occurred during pregnancy, labor, or within 12 weeks postpartum
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: Intervention strategies including medication or surgery
Medication or surgery (delivery or surgery first, or single-stage delivery and surgery) is determined based on gestational age and the type of AD, and also in consideration of the decisions made by the patient and their relatives.
Early-term mortality of mothers and fetuses (or newborns)
All-cause mortality within 30 days after treatment.
Time frame: Death within 30 days after treatment.
Long-term mortality of mothers and children
All-cause mortality during the follow-up period.
Time frame: Through study completion, an average of 3 years.
The incidence of maternal adverse events
The reinterventions for mothers due to aortic and obstetric conditions.
Time frame: Through study completion, an average of 3 years.
The incidence of neonatal developmental abnormalities
Adverse events occurring in newborns during follow-up, including suspected signs of heritable aortic disease and growth and developmental abnormalities (cerebral palsy, intellectual disabilities, etc.)
Time frame: Through study completion, an average of 3 years.
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.